184 related articles for article (PubMed ID: 31417883)
1. Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth.
Topaloğlu R; Gülhan B; Çelegen K; İnözü M; Hayran M; Düzova A; Ozaltin F
Front Pediatr; 2019; 7():313. PubMed ID: 31417883
[No Abstract] [Full Text] [Related]
2. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome.
Fujinaga S; Nishino T; Umeda C; Tomii Y; Watanabe Y; Sakuraya K
Pediatr Nephrol; 2019 Feb; 34(2):353-357. PubMed ID: 30426219
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of rituximab therapy in children with nephrotic syndrome: a 10-year experience from an Iranian pediatric hospital.
Bazargani B; Noparast Z; Khedmat L; Fahimi D; Esfahani ST; Moghtaderi M; Abbasi A; Afshin A; Mojtahedi SY
BMC Pediatr; 2022 Jan; 22(1):36. PubMed ID: 35022016
[TBL] [Abstract][Full Text] [Related]
5. Second-line immunosuppressive treatment of childhood nephrotic syndrome: a single-center experience.
Kim J; Patnaik N; Chorny N; Frank R; Infante L; Sethna C
Nephron Extra; 2014 Jan; 4(1):8-17. PubMed ID: 24575119
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of steroid-resistant nephrotic syndrome: tubular proteinuria and enzymuria.
Vallés P; Peralta M; Carrizo L; Martin L; Principi I; Gonzalez A; Manucha W
Pediatr Nephrol; 2000 Dec; 15(3-4):252-8. PubMed ID: 11149121
[TBL] [Abstract][Full Text] [Related]
7. Association of HLA-DR/DQ alleles and haplotypes with nephrotic syndrome.
Ramanathan AS; Senguttuvan P; Chinniah R; Vijayan M; Thirunavukkarasu M; Raju K; Mani D; Ravi PM; Rajendran P; Krishnan JI; Karuppiah B
Nephrology (Carlton); 2016 Sep; 21(9):745-52. PubMed ID: 26566811
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab.
Kamei K; Ogura M; Sato M; Sako M; Iijima K; Ito S
Pediatr Nephrol; 2016 Jan; 31(1):89-95. PubMed ID: 26341251
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of rituximab therapy against intractable steroid-resistant nephrotic syndrome.
Nakagawa T; Shiratori A; Kawaba Y; Kanda K; Tanaka R
Pediatr Int; 2016 Oct; 58(10):1003-1008. PubMed ID: 26865241
[TBL] [Abstract][Full Text] [Related]
10. Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options.
Kemper MJ; Valentin L; van Husen M
Pediatr Nephrol; 2018 Oct; 33(10):1641-1649. PubMed ID: 28879428
[TBL] [Abstract][Full Text] [Related]
11. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Fujinaga S; Hirano D; Mizutani A; Sakuraya K; Yamada A; Sakurai S; Shimizu T
Clin Exp Nephrol; 2017 Aug; 21(4):671-676. PubMed ID: 27558467
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.
Van Horebeek I; Knops N; Van Dyck M; Levtchenko E; Mekahli D
Acta Clin Belg; 2017 Jun; 72(3):147-155. PubMed ID: 27409338
[TBL] [Abstract][Full Text] [Related]
13. Combined Methylprednisolone Pulse Therapy plus Rituximab for Treating a Rare Juvenile Steroid-Resistant Nephrotic Syndrome with Cerebral Venous Sinus Thrombosis: A Case Report.
Sakr HI; Edrees B; Taher HO; Miliany TT; Gazzaz RY; AlRuwaithi AO; Alamer MF; Metawee ME
J Cardiovasc Dev Dis; 2022 Nov; 9(11):. PubMed ID: 36354782
[No Abstract] [Full Text] [Related]
14. Reciprocal Relationship Between HDAC2 and P-Glycoprotein/MRP-1 and Their Role in Steroid Resistance in Childhood Nephrotic Syndrome.
Singh H; Agarwal V; Chaturvedi S; Misra DP; Jaiswal AK; Prasad N
Front Pharmacol; 2019; 10():558. PubMed ID: 31191307
[No Abstract] [Full Text] [Related]
15. Impact of rituximab on height and weight in children with refractory steroid-dependent nephrotic syndrome.
Sato M; Ito S; Ogura M; Kamei K
Pediatr Nephrol; 2014 Aug; 29(8):1373-9. PubMed ID: 24599443
[TBL] [Abstract][Full Text] [Related]
16. Regulatory and effector T cells changes in remission and resistant state of childhood nephrotic syndrome.
Jaiswal A; Prasad N; Agarwal V; Yadav B; Tripathy D; Rai M; Nath M; Sharma RK; Modi DR
Indian J Nephrol; 2014 Nov; 24(6):349-55. PubMed ID: 25484527
[TBL] [Abstract][Full Text] [Related]
17. Rituximab therapy for childhood onset idiopathic nephrotic syndrome: experience of a Portuguese tertiary center.
Gomes R; Mosca S; Bastos-Gomes M; Correia-Costa L; Rocha L; Teixeira A; Costa T; Sameiro-Faria M; Matos P; Mota C
J Bras Nefrol; 2023; 45(3):326-334. PubMed ID: 36259942
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T-cell Changes in Patients with Steroid-Resistant Nephrotic Syndrome after Rituximab Therapy.
Tunçay SC; Hakverdi G; Şenol Ö; Mir S
Saudi J Kidney Dis Transpl; 2021; 32(4):1028-1033. PubMed ID: 35229802
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling of cultured podocytes exposed to nephrotic plasma reveals intrinsic molecular signatures of nephrotic syndrome.
Panigrahi S; Pardeshi VC; Chandrasekaran K; Neelakandan K; Ps H; Vasudevan A
Clin Exp Pediatr; 2021 Jul; 64(7):355-363. PubMed ID: 33147911
[TBL] [Abstract][Full Text] [Related]
20. Shear wave elastography of kidneys in children: utility in distinguishing steroid-resistant and steroid-sensitive nephrotic syndrome.
Gowda H; Bhatia A; Tiewsoh K; Saxena AK; Dawman L; Bansal M; Sodhi KS
Abdom Radiol (NY); 2024 Feb; 49(2):551-559. PubMed ID: 38150144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
